Blueprint Medicines Corporation (BPMC) Ownership

$129.46

north_east
$0.18 (0.14%)
Day's range
$129.46
Day's range
$129.46

Blueprint Medicines Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 08/11/2025 6.42 M $822.48 M   -3.37% 10.09%
BLACKROCK, INC. 08/12/2025 6.12 M $784.26 M   -8.83% 9.62%
PENTWATER CAPITAL MANAGEMENT LP 08/14/2025 3.90 M $499.90 M   100.00% 6.13%
STATE STREET CORP 08/14/2025 2.23 M $285.97 M   -16.88% 3.51%
UBS GROUP AG 08/14/2025 2.17 M $277.77 M   913.55% 3.41%
FIL LTD 08/14/2025 1.76 M $225.53 M   100.00% 2.77%
UBS OCONNOR LLC 08/14/2025 1.71 M $219.65 M   11,427.66% 2.69%
BARCLAYS PLC 08/14/2025 1.56 M $199.57 M   1,101.37% 2.45%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 1.54 M $197.55 M   1.21% 2.42%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 1.46 M $187.78 M   -72.95% 2.30%
GLAZER CAPITAL, LLC 08/14/2025 1.33 M $170.65 M   100.00% 2.09%
NORGES BANK 08/13/2025 1.07 M $137.79 M   100.00% 1.69%
BERYL CAPITAL MANAGEMENT LLC 08/14/2025 1.07 M $136.80 M   100.00% 1.68%
ALPINE ASSOCIATES MANAGEMENT INC. 08/05/2025 1.06 M $135.91 M   100.00% 1.67%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 08/14/2025 1.04 M $132.68 M   100.00% 1.63%
MACQUARIE GROUP LTD 08/14/2025 922.17 K $118.20 M   -28.34% 1.45%
SYQUANT CAPITAL SAS 07/18/2025 805.60 K $103.26 M   100.00% 1.27%
MAGNETAR FINANCIAL LLC 08/12/2025 730.05 K $93.58 M   15,881.76% 1.15%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2025 728.82 K $93.42 M   -15.50% 1.15%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 674.50 K $86.46 M   100.00% 1.06%
BANK OF AMERICA CORP /DE/ 08/14/2025 647.49 K $82.99 M   -9.68% 1.02%
JANE STREET GROUP, LLC 08/14/2025 583.00 K $74.73 M   -17.55% 0.92%
JANE STREET GROUP, LLC 08/14/2025 580.60 K $74.42 M   -20.16% 0.91%
NORTHERN TRUST CORP 08/13/2025 568.92 K $72.92 M   -3.50% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 561.16 K $71.93 M   -6.43% 0.88%
FMR LLC 08/14/2025 558.96 K $71.65 M   -61.00% 0.88%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 08/14/2025 558.77 K $71.62 M   5,413.25% 0.88%
WOODLINE PARTNERS LP 08/14/2025 531.88 K $68.18 M   -1.64% 0.84%
MAN GROUP PLC 08/14/2025 516.26 K $66.17 M   -0.67% 0.81%
INVESCO LTD. 08/13/2025 511.09 K $65.51 M   -48.10% 0.80%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2025 505.96 K $64.85 M   739.32% 0.80%
NUVEEN, LLC 08/12/2025 488.61 K $62.63 M   82.55% 0.77%
NEXPOINT ASSET MANAGEMENT, L.P. 08/14/2025 476.74 K $61.11 M   100.00% 0.75%
TUDOR INVESTMENT CORP ET AL 08/14/2025 468.62 K $60.07 M   2,029.04% 0.74%
BROWN ADVISORY INC 08/13/2025 458.56 K $58.78 M   -21.19% 0.72%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 457.30 K $58.62 M   121.35% 0.72%
FIRST TRUST CAPITAL MANAGEMENT L.P. 08/14/2025 456.07 K $58.46 M   100.00% 0.72%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 435.98 K $55.88 M   -85.81% 0.69%
JPMORGAN CHASE & CO 08/12/2025 418.06 K $53.59 M   -83.32% 0.66%
CLEARBRIDGE INVESTMENTS, LLC 08/12/2025 405.71 K $52.00 M   -39.59% 0.64%
LMR PARTNERS LLP 08/14/2025 395.86 K $50.74 M   3,603.41% 0.62%
QUADRATURE CAPITAL LTD 08/13/2025 382.68 K $49.06 M   100.00% 0.60%
AVORO CAPITAL ADVISORS LLC 08/14/2025 375.00 K $48.07 M   -90.26% 0.59%
READYSTATE ASSET MANAGEMENT LP 08/07/2025 329.83 K $42.28 M   100.00% 0.52%
WHITEBOX ADVISORS LLC 08/14/2025 310.00 K $39.74 M   100.00% 0.49%
TIG ADVISORS, LLC 08/14/2025 305.10 K $39.11 M   100.00% 0.48%
MILLENNIUM MANAGEMENT LLC 08/14/2025 295.88 K $37.93 M   -57.21% 0.47%
SLOTNIK CAPITAL, LLC 08/14/2025 292.69 K $37.52 M   100.00% 0.46%
BELLEVUE GROUP AG 08/14/2025 284.90 K $36.52 M   100.00% 0.45%
JANUS HENDERSON GROUP PLC 08/14/2025 268.93 K $34.48 M   835.43% 0.42%

Blueprint Medicines Corporation institutional Ownership - FAQ's

During the previous two years, 427 institutional investors and hedge funds held shares of Blueprint Medicines Corporation. The most heavily invested institutionals were:

Verition Fund Management LLC: 0

Covestor Ltd: 0

Mariner, LLC: 0

MEEDER ASSET MANAGEMENT INC: 0

US BANCORP \DE\: 0

Virtu Financial LLC: 0

96.61% of Blueprint Medicines Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 23.36 M shares in the last 24 months. This purchase volume represents approximately $3.02 B in transactions.